Union européenne — décisions de la Commission européenne
Retraits et suspensions d'AMM, rappels de lots, ruptures de stock, informations de sécurité, remboursement et nouveaux médicaments — chaque jour, automatiquement. Dernière mise à jour : 09/11/2026 07:50.
Sources : nous suivons les changements à partir de la Base de données publique des médicaments (AMM, commercialisation, disponibilité, taux et prix de remboursement, informations importantes), comparée chaque jour à l'état précédent, et des informations de sécurité de l'ANSM (rappels de lots). Les décisions sur les médicaments autorisés par procédure centralisée proviennent du Registre de l'Union de la Commission européenne (badge UE). Alternatives (même groupe générique ou même substance active) : base de données Lekoskop.
n° EU/1/16/1156 · autorisé le 18/01/2017 · ZINPLAVA is indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in adult an… · Merck Sharp & Dohme B.V. · bezlotoxumab · ATC J06BC03
n° EU/1/16/1156 · autorisé le 18/01/2017 · ZINPLAVA is indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in adult an… · Merck Sharp & Dohme B.V. · bezlotoxumab · ATC J06BC03
n° EU/1/19/1409 · autorisé le 19/12/2019 · Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated wi… · Mundipharma Corporation (Ireland) Limited · pegfilgrastim · ATC L03AA13
n° EU/1/24/1887 · autorisé le 13/01/2025 · Baiama is indicated for adults for the treatment of
• neovascular (wet) age-related macular degeneration (AMD… · Formycon AG · Aflibercept · ATC S01LA05
n° EU/1/26/2062 · Zokovea is indicated for the post exposure prophylaxis of COVID 19 in adults and adolescents aged 12 years and… · Shionogi B.V. · ensitrelvir · ATC J05AE16
n° EU/1/26/2055 · Ubeslo is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non familial) or m… · A. Menarini International Licensing S.A. · Obicetrapib · ATC C10AX
n° EU/1/26/2064 · Myelofibrosis (MF)
Ruxolitinib Viatris is indicated for the treatment of disease-related splenomegaly or … · Viatris Limited · ruxolitinib · ATC L01EJ01
n° EU/1/26/2051 · Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated wi… · QILU PHARMA SPAIN S.L. · pegfilgrastim · ATC L03AA13
n° EU/1/26/2056 · Evlarco is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non familial) or … · A. Menarini International Licensing S.A. · obicetrapib / ezetimibe
n° EU/1/25/2006 · autorisé le 12/02/2026 · Aumseqa as monotherapy is indicated for:
• the first line treatment of adult patients with advanced non small… · SFL Pharmaceuticals Deutschland GmbH · aumolertinib · ATC L01EB11
n° EU/1/26/2066 · Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated wi… · CuraTeQ Biologics s.r.o · Pegfilgrastim · ATC L03AA13
n° EU/1/14/941 · autorisé le 22/08/2014 · This medicinal product is for diagnostic use only.
VIZAMYL is a radiopharmaceutical indicated for Positron Em… · GE Healthcare AS · flutemetamol (18F) · ATC V09AX04
n° EU/1/15/1079 · autorisé le 15/02/2016 · Vaxelis (DTaP-HB-IPV-Hib) is indicated for primary and booster vaccination in infants and toddlers from the ag… · MCM Vaccine B.V. · Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed) · ATC J07CA09
n° EU/1/25/1947 · autorisé le 28/07/2025 · RIULVY is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing … · Neuraxpharm Pharmaceuticals, S.L. · Tegomil fumarate · ATC L04AX10
n° EU/1/23/1730 · autorisé le 31/05/2023 · Briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with… · Neuraxpharm Pharmaceuticals, S.L. · ublituximab · ATC L04AG14
n° EU/1/25/1957 · autorisé le 14/08/2025 · Adult Crohn’s Disease
Usymro is indicated for the treatment of adult patients with moderately to severely ac… · Gedeon Richter Plc. · ustekinumab · ATC L04AC05
n° EU/1/10/638 · autorisé le 27/07/2010 · OZURDEX is indicated for the treatment of adult patients with:
• Visual impairment due to diabetic macular oe… · AbbVie Deutschland GmbH & Co. KG · dexamethasone · ATC S01BA01
n° EU/1/23/1732 · autorisé le 31/05/2023 · Lacosamide Adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secon… · Extrovis EU Kft. · lacosamide · ATC N03AX18
n° EU/1/15/1064 · autorisé le 16/12/2015 · Imlygic is indicated for the treatment of adults with unresectable melanoma that is regionally or distantly me… · Amgen Europe B.V. · talimogene laherparepvec · ATC L01XL02
n° EU/1/25/2006 · autorisé le 12/02/2026 · Aumseqa as monotherapy is indicated for:
• the first line treatment of adult patients with advanced non small… · SFL Pharmaceuticals Deutschland GmbH · aumolertinib · ATC L01EB11
n° EU/1/05/312 · autorisé le 13/10/2005 · Treatment of narcolepsy with cataplexy in adult patients, adolescents and children from the age of 7 years. · UCB Pharma S.A. · Sodium oxybate · ATC N07XX04
n° EU/1/26/2060 · Nezglyal is indicated for the treatment of Cerebral Adrenoleukodystrophy (cALD) in males with Adrenoleukodystr… · Minoryx Therapeutics S.L. · leriglitazone · ATC A16AX23
n° EU/1/17/1175 · autorisé le 22/03/2017 · Daptomycin is indicated for the treatment of the following infections (see sections 4.4 and 5.1).
- Adult an… · Pfizer Europe MA EEIG · daptomycin · ATC J01XX09
n° EU/1/24/1833 · autorisé le 25/07/2024 · Cejemly in combination with platinum-based chemotherapy is indicated for the first line treatment of adults wi… · CStone Pharmaceuticals Ireland Limited · sugemalimab · ATC L01FF11
n° EU/1/21/1608 · autorisé le 06/01/2022 · Adults
Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for wei… · Novo Nordisk A/S · semaglutide · ATC A10BJ06
n° EU/1/23/1770 · autorisé le 07/12/2023 · ELREXFIO is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple… · Pfizer Europe MA EEIG · elranatamab · ATC L01FX32
Lekoskop